Meta‐analysis of health‐related quality of life after minimally invasive versus open oesophagectomy for oesophageal cancer.
Published: 20th June 2017
Authors: J. H. Kauppila, S. Xie, A. Johar, S. R. Markar, P. Lagergren
The aim of this systematic review and meta‐analysis was to compare health‐related quality of life (HRQoL) outcomes between minimally invasive and open oesophagectomy for cancer at different postoperative time points.
A search of PubMed (MEDLINE), Web of Science, Embase, Scopus, CINAHL and the Cochrane Library was performed for studies that compared open with minimally invasive oesophagectomy. A random‐effects meta‐analysis was conducted for studies that measured HRQoL scores using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ‐C30 and QLQ‐OES18 questionnaires. Mean differences (MDs) greater than 10 in scores were considered clinically relevant. Pooled effects of MDs with 95 per cent confidence intervals were estimated to assess statistical significance.
Nine studies were included in the qualitative analysis, involving 1157 patients who had minimally invasive surgery and 907 patients who underwent open surgery. Minimally invasive surgery resulted in better scores for global quality of life (MD 11·61, 95 per cent c.i. 3·84 to 19·39), physical function (MD 11·88, 3·92 to 19·84), fatigue (MD −13·18, −17·59 to −8·76) and pain (MD −15·85, −20·45 to −11·24) compared with open surgery at 3 months after surgery. At 6 and 12 months, no significant differences remained.
Patients report better global quality of life, physical function, fatigue and pain 3 months after minimally invasive surgery compared with open surgery. No such differences remain at longer follow‐up of 6 and 12 months.Read more
You may also be interested in
Authors: C. Lin, H. Liu, H. Zhang, Y. Cao, R. Li, S. Wu et al.
Notes: Tumour microenvironment is important
Corrigendum: Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer. BJS 2017; 104: 947-947.
Authors: J. M. Findlay, K. M. Bradley, L. M. Wang, J. M. Franklin, E. J. Teoh, F. V. Gleeson et al.
Preoperative imaging and prediction of oesophageal conduit necrosis after oesophagectomy for cancer.
Authors: P. Lainas, D. Fuks, S. Gaujoux, Z. Machroub, A. Fregeville, T. Perniceni et al.
Notes: Vascular abnormalities may be causal
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.
Authors: M. Bencivenga, G. Verlato, D.‐S. Han, D. Marrelli, F. Roviello, H.‐K. Yang et al.
Notes: Good performance
Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. BJS 2017; 104: 1045-1052.
Authors: H. Kim, S. W. Ahn, S. K. Hong, K. C. Yoon, H.‐S. Kim, Y. R. Choi et al.
Notes: Selected patients benefit
Authors: Z.‐X. Wang, G.‐X. Li, Z.‐W. Zhou, Z.‐P. Huang, F. Wang, R.‐H. Xu et al.
Notes: Facilitates individualized treatment
Randomized clinical trial
Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer. BJS 2017; 104: 1003-1009.
Authors: T. Ojima, M. Nakamori, M. Nakamura, M. Katsuda, K. Hayata, T. Kato et al.
Notes: Prevention of atrial fibrillation is beneficial
Geographic and socioeconomic factors affecting delivery of bariatric surgery across high‐ and low‐utilization healthcare systems. BJS 2017; 104: 891-897.
Authors: A. G. Doumouras, F. Saleh, A. M. Sharma, S. Anvari, S. Gmora, M. Anvari et al.
Notes: Differences between rural and urban areas
Meta‐analysis of biomarkers predicting risk of malignant progression in Barrett’s oesophagus. BJS 2017; 104: 493-502.
Authors: K. Altaf, J.‐J. Xiong, D. De la Iglesia, L. Hickey, A. Kaul
Notes: Limited clinical usefulness at present
Randomized clinical trial
Randomized clinical trial of 270° posterior versus 180° anterior partial laparoscopic fundoplication for gastro‐oesophageal reflux disease. BJS 2017; 104: 843-851.
Authors: D. J. Roks, J. H. Koetje, J. E. Oor, J. A. Broeders, V. B. Nieuwenhuijs, E. J. Hazebroek et al.
Notes: No major differences in outcomes
Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer. BJS 2017; 104: 877-884.
Authors: J. S. Chang, K. H. Kim, H. I. Yoon, W. J. Hyung, S. Y. Rha, H. S. Kim et al.
Notes: Can be predicted
Outcomes of laparoscopic gastric bypass in a randomized clinical trial compared with a concurrent national database. BJS 2017; 104: 562-569.
Authors: E. Stenberg, E. Szabo, J. Ottosson, I. Näslund
Notes: Similar results demonstrating external validity